|
⚲
|
| Keyboard |
| Cuss Francis M
✚
|
|
|---|---|
| CIK # | 0001490216 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001490216] | |
| 4 | [0001490216] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Mural Oncology PLC | |
| Cuss Francis M | |
| Rubius Therapeutics Inc | |
| Bristol Myers Squibb Co |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Mural Oncology PLC MURA
Stock Option (right to buy) · derivative
|
2025-12-05 | Disposed to issuer | 15,021 | ||
|
Mural Oncology PLC MURA
Stock Option (right to buy) · derivative
|
2025-12-05 | Disposed to issuer | 8,637 | ||
|
Mural Oncology PLC MURA
Stock Option (right to buy) · derivative
|
2025-12-05 | Disposed to issuer | 8,462 | ||
|
Mural Oncology PLC MURA
Stock Option (right to buy) · derivative
|
2025-06-11 | Grant | 8,637 | $0.00 | |
|
Mural Oncology PLC MURA
Stock Option (right to buy) · derivative
|
2024-05-30 | Grant | 8,462 | $3.35 | 28,348 |
|
Mural Oncology PLC MURA
Stock Option (right to buy) · derivative
|
2023-12-14 | Grant | 15,021 | $0.00 | |
|
Rubius Therapeutics Inc RUBY
Stock Option (Right to Buy) · derivative
|
2022-05-12 | Grant | 25,000 | $0.00 | |
|
Rubius Therapeutics Inc RUBY
Stock Option (Right to Buy) · derivative
|
2021-05-12 | Grant | 25,000 | $0.00 | |
|
Rubius Therapeutics Inc RUBY
Stock Option (Right to Buy) · derivative
|
2020-05-21 | Grant | 25,000 | $0.00 | |
|
Rubius Therapeutics Inc RUBY
Stock Option (Right to Buy) · derivative
|
2019-05-23 | Grant | 25,000 | $0.00 | |
|
Rubius Therapeutics Inc RUBY
Common Stock
|
2018-07-20 | Buy | 10,000 | $23.00 | 230,000 |
|
Rubius Therapeutics Inc RUBY
Stock Option (Right to Buy) · derivative
|
2018-07-17 | Grant | 25,000 | $0.00 | |
|
Bristol Myers Squibb Co BMY
Common Stock, $0.10 par value
|
2017-03-10 | Option exercise | 4,982 | $0.00 | |
|
Bristol Myers Squibb Co BMY
Common Stock, $0.10 par value
|
2017-03-10 | Tax withheld | 2,759 | $58.32 | 160,905 |
|
Bristol Myers Squibb Co BMY
Common Stock, $0.10 par value
|
2017-03-10 | Other | 41 | $0.00 | |
|
Bristol Myers Squibb Co BMY
Common Stock, $0.10 par value
|
2017-03-10 | Tax withheld | 24,864 | $58.32 | 1,450,068 |
|
Bristol Myers Squibb Co BMY
Common Stock, $0.10 par value
|
2017-03-10 | Option exercise | 47,953 | $0.00 | |
|
Bristol Myers Squibb Co BMY
Common Stock, $0.10 par value
|
2017-03-10 | Tax withheld | 2,562 | $58.32 | 149,416 |
|
Bristol Myers Squibb Co BMY
Common Stock, $0.10 par value
|
2017-03-10 | Other | 831 | $0.00 | |
|
Bristol Myers Squibb Co BMY
Common Stock, $0.10 par value
|
2017-03-10 | Option exercise | 2,740 | $0.00 | |
| showing 20 of 193 most recent transactions | |||||